• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Optimization of a cultivation process for recombinant protein production by Escherichia coli.

作者信息

Yang X M

机构信息

R&D Lab, New Brunswick Scientific Co. Inc., Edison, New Jersey 08818-4005.

出版信息

J Biotechnol. 1992 May;23(3):271-89. doi: 10.1016/0168-1656(92)90075-k.

DOI:10.1016/0168-1656(92)90075-k
PMID:1368246
Abstract

A single-stage fed-batch bioprocess for the production of a recombinant protein beta-galactosidase, by E. coli has been developed. The XL1-blue strain of E. coli which harbors a multi-number foreign plasmid PT was cultured in a reformulated medium. Critical medium components were selected and their respective concentrations were optimized with the Orthogonal Table method. An exponential substrate feeding schedule was used to maintain optimum conditions. Inhibition of growth and protein expression caused by excessive concentrations of glucose and acetate was investigated and subsequently minimized with an incremental nutrient feeding schedule which limited the specific growth rate of a culture. The program necessary to facilitate the control of substrate addition is fully described. This program has been used with a 2.5 l bioreactor and a commercially available software package for optimization without on-line or off-line measurement of optical density (OD), CO2, glucose or acetate. The optimized fed-batch process limited the acetate concentration to less than 20 mM; maintained an exponential growth phase for 50 h; and produced a cell density of 51 g l-1 dry cell weight (DCW) or 154 OD600 with a beta-galactosidase activity of 990 U ml-1.

摘要

相似文献

1
Optimization of a cultivation process for recombinant protein production by Escherichia coli.
J Biotechnol. 1992 May;23(3):271-89. doi: 10.1016/0168-1656(92)90075-k.
2
Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].在大肠杆菌BL21(DE3)[pET - 3aT2M2]高细胞密度补料分批培养中提高人迷你胰岛素原的产量。
Biotechnol Prog. 1997 May-Jun;13(3):249-57. doi: 10.1021/bp970018m.
3
[High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].[采用两阶段补料策略进行重组大肠杆菌的高密度培养以生产肿瘤坏死因子相关凋亡诱导配体(TRAIL)]
Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):408-13.
4
High cell density cultivation and recombinant protein production with Escherichia coli in a rocking-motion-type bioreactor.在摇动机型生物反应器中用大肠杆菌进行高密度培养和重组蛋白生产。
Microb Cell Fact. 2010 May 30;9:42. doi: 10.1186/1475-2859-9-42.
5
Reduction of acetate accumulation in Escherichia coli cultures for increased recombinant protein production.减少大肠杆菌培养物中乙酸盐的积累以提高重组蛋白产量。
Metab Eng. 2008 Mar;10(2):97-108. doi: 10.1016/j.ymben.2007.10.003. Epub 2007 Nov 17.
6
Use of fed-batch cultivation for achieving high cell densities for the pilot-scale production of a recombinant protein (phenylalanine dehydrogenase) in Escherichia coli.采用补料分批培养法在大肠杆菌中实现高细胞密度,用于重组蛋白(苯丙氨酸脱氢酶)的中试规模生产。
Biotechnol Prog. 2006 May-Jun;22(3):889-97. doi: 10.1021/bp050327+.
7
Tracking the acetate threshold using DO-transient control during medium and high cell density cultivation of recombinant Escherichia coli in complex media.在复杂培养基中对重组大肠杆菌进行中高细胞密度培养时,利用溶解氧瞬态控制追踪乙酸盐阈值。
Biotechnol Bioeng. 2003 Nov 5;84(3):314-23. doi: 10.1002/bit.10772.
8
Kinetic study and optimization of recombinant human tumor necrosis factor-alpha (rhTNF-α) production in .重组人肿瘤坏死因子-α(rhTNF-α)在.中的生产动力学研究及优化
Prep Biochem Biotechnol. 2021;51(3):267-276. doi: 10.1080/10826068.2020.1815056. Epub 2020 Sep 2.
9
The use of fed batch cultivation for achieving high cell densities in the production of a recombinant protein in Escherichia coli.
FEMS Microbiol Rev. 1994 May;14(1):53-6. doi: 10.1111/j.1574-6976.1994.tb00072.x.
10
High-level production of bacillus subtilis glycine oxidase by fed-batch cultivation of recombinant Escherichia coli Rosetta (DE3).通过重组大肠杆菌Rosetta (DE3) 的补料分批培养实现枯草芽孢杆菌甘氨酸氧化酶的高水平生产。
Biotechnol Prog. 2007 May-Jun;23(3):645-51. doi: 10.1021/bp0603917. Epub 2007 May 3.

引用本文的文献

1
Production of recombinant scorpion antivenoms in E. coli: current state and perspectives.重组蝎类抗蛇毒血清在大肠杆菌中的生产:现状与展望。
Appl Microbiol Biotechnol. 2023 Jul;107(13):4133-4152. doi: 10.1007/s00253-023-12578-1. Epub 2023 May 18.
2
Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors.通过优化五个关键因素提高大肠杆菌中胰岛素样生长因子I蛋白的产量。
Iran J Pharm Res. 2015 Summer;14(3):907-17.
3
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.
工业生产重组治疗药物在大肠杆菌中的应用及其最新进展。
J Ind Microbiol Biotechnol. 2012 Mar;39(3):383-99. doi: 10.1007/s10295-011-1082-9. Epub 2012 Jan 18.
4
Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiagnosis of paracoccidioidomycosis.巴西副球孢子菌27千道尔顿重组蛋白在副球孢子菌病血清诊断中的应用。
Clin Diagn Lab Immunol. 1998 Nov;5(6):826-30. doi: 10.1128/CDLI.5.6.826-830.1998.
5
The relationship between growth enhancement and pet expression in Escherichia coli.大肠杆菌中生长增强与pet表达之间的关系。
Appl Biochem Biotechnol. 1996 Spring;57-58:277-92. doi: 10.1007/978-1-4612-0223-3_25.